Monitoring of Molecular Markers of Artemisinin Resistance Through Repeated Cross-sectional Assessments in DR Congo, Nigeria and Uganda

CompletedOBSERVATIONAL
Enrollment

916

Participants

Timeline

Start Date

July 27, 2018

Primary Completion Date

July 31, 2020

Study Completion Date

July 31, 2020

Conditions
Severe Malaria
Interventions
OTHER

Blood sample (combined with malaria RDT) followed by gentoyping analysis

Finger-prick blood samples collected from children with signs of severe febrile illness and a positive mRDT presenting to community-based providers and referral facilities ; analysis for mutations in portions of a P. falciparum gene encoding kelch (K13)-propeller domain

Trial Locations (7)

Unknown

Health Zone of Kenge, Kenge

Health Zone of Ipamu, Ipamu

Health Zone of Kingandu, Kingandu

Adamawa State, selected LGAs, Yola

Apac District, Lira

Kole District, Lira

Oyam District, Lira

All Listed Sponsors
collaborator

Clinton Health Access Initiative, Nigeria

OTHER

collaborator

Akena Associates Ltd.

UNKNOWN

collaborator

Kinshasa School of Public Health

OTHER

collaborator

Makerere University

OTHER

lead

Swiss Tropical & Public Health Institute

OTHER

NCT04037332 - Monitoring of Molecular Markers of Artemisinin Resistance Through Repeated Cross-sectional Assessments in DR Congo, Nigeria and Uganda | Biotech Hunter | Biotech Hunter